Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease

被引:12
|
作者
Franzmeier, Nicolai [1 ,2 ,3 ,4 ]
Dehsarvi, Amir [1 ]
Steward, Anna [1 ]
Biel, Davina [1 ]
Dewenter, Anna [1 ]
Roemer, Sebastian Niclas [1 ]
Wagner, Fabian [1 ]
Gross, Mattes [1 ,5 ]
Brendel, Matthias [2 ,5 ]
Moscoso, Alexis [3 ,4 ]
Arunachalam, Prithvi [3 ,4 ]
Blennow, Kaj [3 ,4 ,6 ]
Zetterberg, Henrik [3 ,4 ,6 ,7 ,8 ,9 ,10 ]
Ewers, Michael [1 ,11 ]
Schoell, Michael [3 ,4 ,12 ,13 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany
[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden
[4] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Dept Psychiat & Neurochem, Gothenburg, Sweden
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[7] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[8] UCL, UK Dementia Res Inst, London, England
[9] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[10] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Sch Med & Publ Hlth, Madison, WI USA
[11] German Ctr Neurodegenerat Dis DZNE, Munich, Germany
[12] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[13] UCL, Queen Sq Inst Neurol, Dementia Res Ctr, London, England
基金
欧盟地平线“2020”; 瑞典研究理事会;
关键词
MESSENGER-RNA; MOUSE MODEL; HYPERACTIVITY; ANTIBODIES; RELEASE; NEURONS; BETA;
D O I
10.1038/s41467-023-44374-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In Alzheimer's disease, amyloid-beta (A beta) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. A beta induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether A beta-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer's spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster A beta-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between A beta and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster A beta-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer's disease. Trans-synaptic tau spread drives neurodegeneration in Alzheimer's disease. This study shows that GAP-43, a marker of synaptic abnormality, is linked to faster tau spread, showing that synaptic changes may contribute to tau spreading in Alzheimer's disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Tau Accumulation and Network Breakdown in Alzheimer's Disease
    Watanabe, Hirohisa
    Bagarinao, Epifanio
    Yokoi, Takamasa
    Yamaguchi, Hiroshi
    Ishigaki, Shinsuke
    Mausuda, Michihito
    Katsuno, Masahisa
    Sobue, Gen
    TAU BIOLOGY, 2019, 1184 : 231 - 240
  • [22] Elevation of CSF tau in early stage Alzheimer's disease
    Seubert, P
    Motter, R
    Schenk, D
    Green, R
    Chang, L
    Miller, B
    Clark, C
    Galasko, D
    NEUROLOGY, 1996, 46 (02) : 5001 - 5001
  • [23] Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
    Brier, Matthew R.
    Gordon, Brian
    Friedrichsen, Karl
    McCarthy, John
    Stern, Ari
    Christensen, Jon
    Owen, Christopher
    Aldea, Patricia
    Su, Yi
    Hassenstab, Jason
    Cairns, Nigel J.
    Holtzman, David M.
    Fagan, Anne M.
    Morris, John C.
    Benzinger, Tammie L. S.
    Ances, Beau M.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (338)
  • [24] Modified tau protein in CSF for diagnosis of Alzheimer's disease
    Tanaka, T
    Yamamori, H
    Takeda, M
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 358 - 359
  • [25] CSF tau and Aβ42:: Logical biomarkers for Alzheimer's disease?
    Galasko, D
    NEUROBIOLOGY OF AGING, 1998, 19 (02) : 117 - 119
  • [26] TAU CONFORMATIONS: NOVEL CSF BIOMARKERS FOR ALZHEIMER'S DISEASE
    Driver, J.
    Chen, C.
    Kowall, N.
    Lu, K.
    GERONTOLOGIST, 2012, 52 : 135 - 136
  • [27] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Hanna Rosenmann
    Journal of Molecular Neuroscience, 2012, 47 : 1 - 14
  • [28] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Rosenmann, Hanna
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 47 (01) : 1 - 14
  • [29] Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
    Fossati, Silvia
    Ramos Cejudo, Jaime
    Debure, Ludovic
    Pirraglia, Elizabeth
    Sone, Je Yeong
    Li, Yi
    Chen, Jingyun
    Butler, Tracy
    Zetterberg, Henrik
    Blennow, Kaj
    de Leon, Mony J.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 483 - 492
  • [30] Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease
    Zhang, Huiqin
    Cao, Yu
    Ma, Lina
    Wei, Yun
    Li, Hao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9